Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Sarepta Therapeutics, Inc.    SRPT

SAREPTA THERAPEUTICS, INC.

(SRPT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on SAREPTA THERAPEUTICS, INC.
01/12SAREPTA THERAPEUTICS : Citigroup Downgrades Sarepta Therapeutics to Neutral from..
MT
01/11SAREPTA THERAPEUTICS : UBS Cuts Sarepta Therapeutics to Neutral From Buy, PT to ..
MT
01/08SAREPTA THERAPEUTICS : Baird Adjusts Price Target on Sarepta Therapeutics to $11..
MT
01/08SAREPTA THERAPEUTICS : SVB Leerink Adjusts Price Target on Sarepta Therapeutics ..
MT
01/08SAREPTA THERAPEUTICS : Mizuho Adjusts Price Target on Sarepta Therapeutics to $1..
MT
01/08SAREPTA THERAPEUTICS : Cantor Fitzgerald Adjusts Price Target on Sarepta Therape..
MT
01/08SAREPTA THERAPEUTICS : Cowen Adjusts Price Target on Sarepta Therapeutics to $11..
MT
01/08SAREPTA THERAPEUTICS : Needham Adjusts Sarepta Therapeutics' Price Target to $16..
MT
01/08SAREPTA THERAPEUTICS : Goldman Sachs Adjusts Price Target for Sarepta Therapeuti..
MT
01/08SAREPTA THERAPEUTICS : Barclays Adjusts Price Target for Sarepta Therapeutics to..
MT
01/08SAREPTA THERAPEUTICS : Credit Suisse Adjusts Sarepta Therapeutics' Price Target ..
MT
01/08SAREPTA THERAPEUTICS : JP Morgan Downgrades Sarepta Therapeutics to Underweight ..
MT
01/08SAREPTA THERAPEUTICS : Raymond James Downgrades Sarepta Therapeutics to Market P..
MT
01/08SAREPTA THERAPEUTICS : Morgan Stanley Downgrades Sarepta Therapeutics to Equal W..
MT
01/08SAREPTA THERAPEUTICS : RBC Adjusts Sarepta Therapeutics' PT to $143 From $200 on..
MT
2020SAREPTA THERAPEUTICS : Credit Suisse Adjusts Sarepta Therapeutics' Price Target ..
MT
2020Berenberg Bank Initiates Coverage on Sarepta Therapeutics With Hold Rating, $..
MT
2020SVB Leerink Adjusts Sarepta Therapeutics' Price Target to $197 from $214, Kee..
MT
2020Credit Suisse Adjusts Sarepta Therapeutics' Price Target to $162 From $167, M..
MT
2020RBC Capital Adjusts Sarepta Therapeutics' Price Target to $191 From $200, Mai..
MT
2013Sarepta shares jump after disappointing test for rival drug
RE
Upcoming event on SAREPTA THERAPEUTICS, INC.